Ask AI

Are You Achieving "HiSCRs" in Hidradenitis Suppurativa? Expert Guidance for Navigating Diagnosis and Treatment Advancement

Video
This activity is available for 1.00 CME/CE credit(s).

Released: August 25, 2026

Expiration: August 24, 2027

See Activity Collection

Hidradenitis suppurativa (HS) is a chronic, inflammatory skin disease associated with significant burdens, including delayed recognition, diagnostic challenges, and health disparities. This on-demand webcast features an HS expert’s insights on current approaches to early diagnosis and evaluation, the latest evidence for new and emerging therapies, and practical strategies for providing individualized, patient-centered care in your practice.

Achieving HiSCRs in HS care

Pre Assessment

Assess your current knowledge and clinical approach before beginning your video.
1.

How many people with hidradenitis suppurativa do you provide care for in a typical week?

2.

For those who practice in academic or community settings, please indicate your practice setting:

3.

Which of the following best describes your current role?

4.

A 29-yr-old Black woman has recurrent painful nodules in the axillae and groin for 10 yr. She has been repeatedly treated for furunculosis with incision and drainage and antibiotics. Examination shows inflammatory nodules and double-ended comedones.

Based on the latest HS diagnostic criteria, which approach is most appropriate?

5.

A 36-yr-old man has stage III HS. His symptoms persist despite prolonged oral antibiotic therapy. His HCP discusses newer therapies targeting HS pathogenesis.

How would you explain to the patient why a newer targeted therapy is being recommended?

6.

A 34-yr-old patient with a 4-yr history of moderate to severe HS presents to your clinic with painful, recurring nodules and draining tunnels. The patient has not responded adequately to prior conventional therapies. 

Based on Phase III clinical trial data, which of the following efficacy outcomes has been demonstrated with IL-17 inhibitors in patients with HS?